Dr Gerard Morris
1987 - PhD Radiation Biology, University of London, UK
1982 - MSc Electron Microscopy, University of Keele, UK
イギリス在住。放射線生物学、放射線療法、化学療法に重点を置いた腫瘍学を学ぶ。科学者また「principal investigator」としてオックスフォード大学に在籍中は、がん治療へ向けての新薬や新たな放射線療法の開発に取り組む。近年ではバイオテクノロジー産業の分野で科学者・メディカルライターとして活躍。腫瘍学、感染症、加齢性黄斑変性症、肥満症等を含む様々な疾患の治療の研究に関与。Brookhaven National Laboratory（米国）の客員研究員であり、50件以上におよぶピアレビュージャーナル論文・本の章の執筆経験を持つ。
Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.
